This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Swindell, S. L. Articles by Delaney, J. Search for Related Content PubMed PubMed Citation Articles by Swindell, S. L. Articles by Delaney, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LEAD COMPOUNDS LEAD, ELEMENTAL Medline Plus Health Information Lead Poisoning Social Bookmarking                         What's this?

Home Abatement and Blood Lead Changes in Children With Class III Lead Poisoning

Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts

Evan Charney

Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts

Mary Jean Brown

Department of Public Health, Commonwealth of Massachusetts, Boston, Massachusetts

Joanne Delaney

Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts

We studied the effect of home abatement on blood lead (PbB) levels in children from central Massachusetts who had not undergone chelation therapy and whose homes were abated between 1987 and 1990, when stricter abatement guidelines were enacted. One hundred and thirty-two children with a mean preabatement PbB of 25.9 µg/dL (1.25 µmol/L) were studied; their mean postabatement PbB (up to 1 year later) was 21.1 µg/dL (1.02 µmol/L) (P <.001). This reduction correlated with preabatement PbB; 32 of 33 (97%) with preabatement PbB 30 µg/dL (1.45 µmol/L) were lower postabatement, and 64 of 79 (81%) with PbB 20 to 29 µg/dL (0.97-1.40 µmol/L) were lower. However, in children with preabatement PbB <20 µg/dL (<0.97 µmol/L), only seven of 20 (35%) were lower postabatement and, in fact, there was a significant rise in PbB from 16.8 to 19.3 µg/dL (0.81 to 0.93 µmol/L) (P= 0.05). Continued improvement in home abatement technology is needed if that strategy is to be effective in achieving the lower PbB levels now mandated in the 1991 Centers for Disease Control guidelines. Primary prevention of the initial blood lead level elevation remains the most desirable strategy.

Clinical Pediatrics, Vol. 33, No. 9, 536-541 (1994)
DOI: 10.1177/000992289403300905


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Rischitelli, P. Nygren, C. Bougatsos, M. Freeman, and M. Helfand Screening for Elevated Lead Levels in Childhood and Pregnancy: An Updated Summary of Evidence for the US Preventive Services Task Force Pediatrics, December 1, 2006; 118(6): e1867 - e1895. [Abstract] [Full Text] [PDF]

				J. P. Duckart An Evaluation of the Baltimore Community Lead Education and Reduction Corps (CLEARCorps) Program Eval Rev, June 1, 1998; 22(3): 373 - 402. [Abstract] [PDF]